Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07024940

Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance

The investigators are conducting a study to see how a commercial pre-workout supplement, coffee, and water affect how well people perform. The study is conducted across four visits. The first visit is to assess the participants, and the next three visits are for testing. Each participant will drink a randomly assigned beverage 45 minutes before testing. Throughout the study, the participants will complete three testing days-each at least three days apart-so they can try all three drinks. The first test is the Wingate test, where the participants pedal as fast as they can for 30 seconds against a set resistance. The second test is a 1-mile treadmill run/walk on an incline, where the participant tries to complete the distance as fast as possible. The third test measures reaction time using light-up buttons to see how quickly a participant responds by touching them. These tests will help determine if any of the drinks improve performance. The results can help people choose the best drink for their workouts or races.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Saint Louis University

St Louis, Missouri, 63103, United States

Location status: Recruiting

Location contact

Dylan Moffatt, BSc

SUB_INVESTIGATOR

Hossein Rafiei, PhD

CONTACT

[email protected]

314-977-8675

About this study

This study is being conducted to evaluate how a commercial pre-workout supplement with multiple ingredients and coffee affects how people perform during exercise testing. The study takes place over 4 separate lab visits. The first lab visit is an assessment for each participant to help define the population to be tested. Then, three testing visits will be identical in design but will differ in the intervention given to the participant. Each participant will consume the pre-workout, coffee, and a placebo in a randomized order. At the beginning of each visit, the participant will consume their assigned beverage. The participants will then start a warm-up after 30 minutes of consuming the assigned beverage. After the 10-minute warm-up, the participant will rest for five minutes before conducting the testing. In the testing visits, participants will conduct a 1-mile treadmill run, in which the participant will determine their speed using a 1% incline. This allows the participant to control the speed, allowing them to try as hard as they can. The next test will be a Wingate cycle ergometer test. The test contains a 20-second warm-up followed by a three-second period where the participant will pedal as fast as they can until the test begins, then they will do an all-out effort for 30 seconds. The participant will then conduct an agility reaction time test to measure any benefits the interventions may have on cognitive function.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are a healthy male or female adult aged 18-35 years old
  • Regularly engaged in resistance training or aerobic exercise at least 3 times per week, at least 30 minutes a week for the past 6 months
  • Able to provide written informed consent

Exclusion criteria

  • Have a history of or currently have a cardiovascular or metabolic disease (e.g., diabetes, prediabetes, hypertension, arrhythmia, heart attack, stroke, non-alcoholic fatty liver disease, chronic kidney disease)
  • History of seizure disorder
  • Currently taking prescription medications (e.g., beta-blockers, antidepressants, anti-anxiety, pain killers)
  • Currently pregnant, breastfeeding, pregnant within the past year, or a chance of being pregnant
  • Recent participation in another clinical trial
  • Any sensitivities to caffeine, coffee, berries, maltodextrin, monk fruit extract, or any known food allergies
  • Currently undertaking serious exercise training (6 or more days of the week)
  • Recently started taking creatine or beta-alanine daily within the past 3 months. (If greater than 3 months taken consistently is okay)

Treatment and study plan

Ethiopian Coffee

Other

Ethiopian Coffee is used as a real-world example of one of the most common drinks in the world.

Supplement

Dietary Supplement

A pre-workout supplement that contains anthocyanins and caffeine as ergogenic aids

Water (Placebo)

Other

Bottled water acting as the placebo

Primary outcomes

  1. Change in anaerobic power measured by a 30-second all-out effort on a cycle ergometer

    Time frame: At 45 minutes post-dose for each intervention condition

    The primary outcome measured is the change in anaerobic power measured by a 30-second all-out effort on a cycle ergometer using the Wingate testing. This test will determine whether the interventions confer any performance benefit compared to the placebo.

Secondary outcomes

  1. 1-mile Treadmill time trial

    Time frame: At 45 minutes post-dose for each intervention condition

    The 1-mile treadmill time trial will help determine if either of the interventions allows for a faster time, translating to an increase in physical performance.

  2. Agility Reaction Time

    Time frame: At 45 minutes post-dose for each intervention condition

    Agility reaction time will be measured with light-up buttons, where participants will need to touch the light to measure time. This test will identify if either intervention can reduce reaction time, which may reflect improvements in neuromotor performance.

Study contacts

Contact information is provided by the study sponsor or research team.

Dylan Moffatt, Bsc

CONTACT

[email protected]

314-977-8675

Sponsors and collaborators

Lead sponsor

St. Louis University

Other

Registry information

Official study title

Acute Effects of Coffee, Anthocyanin-Caffeine Supplement and Placebo on Exercise Performance Markers

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 17, 2025
Registry last updated
Aug 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.